BROADWOOD PARTNERS, L.P. - Director, 10%+ Owner at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
LCTX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by BROADWOOD PARTNERS, L.P. since 12 Mar 2025

Holdings reported by BROADWOOD PARTNERS, L.P. for Lineage Cell Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 49,560,992 $37,666,354 $0.7600 27 Jan 2025 Direct
Common Shares 49,560,992 $37,666,354 $0.7600 27 Jan 2025 Indirect
Common Warrant 7,894,737 27 Jan 2025 Direct Common Shares
Common Warrant 7,894,737 27 Jan 2025 Indirect Common Shares

Transactions reported by BROADWOOD PARTNERS, L.P. for Lineage Cell Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.